TenQ · fact sheet · filings current to · price as of
Hims & Hers Health (HIMS)
The business itself is the question here - 9 of 36 checks passed.
Latest close : $27.71, -0.4% on the day; -55.8% from the 52-week high. Refreshed every trading night.
Full analysis: report · all charts. Financial statements are computed from SEC EDGAR XBRL filings, current to . The share price and everything built on it (market cap, multiples, yields, the Value and Trend checks) are refreshed every trading night; this page shows the close of . Not investment advice.
Key figures
| Share price (delayed close) | $27.71 |
| Market cap | $6.5B |
| 52-week range | $14.52 - $62.76 |
| P/E | - |
| P/E, own 2-year median | - |
| P/S | 2.5x |
| Free cash flow yield | 1.0% |
| Dividend yield | - |
| Revenue (TTM) | $2.6B |
| Net income (TTM) | $-142M |
| Free cash flow (TTM) | $62M |
| Gross margin | 68.4% |
| Operating margin | -6.0% |
| Return on equity | -43.8% |
| Revenue growth (1y) | +28.0% |
| Revenue CAGR (3y) | +64.5% |
| Debt / equity | - |
| Cash & short-term investments | $610M |
| Shares outstanding | 0m (market data - this filer tags share counts only per class, 2019-06-30) |
The score: 9 of 36 checks passed
Six chapters, six pass/fail checks each. Five are computed from the filings; Trend is price behaviour, and says so.
Is HIMS stock cheap or expensive right now?
Value · 0 of 6 checks passed. Expensive against its own history and its sector (judged on sales - not yet profitable) - you're paying up for what you get. chapter →
Is Hims & Hers Health still growing?
Growth · 3 of 6 checks passed. Growing, but with caveats - revenue +28.0% over the last year. chapter →
Does Hims & Hers Health make real money?
Quality · 2 of 6 checks passed. Profitability is thin or negative - the growth isn't turning into money yet. chapter →
Can Hims & Hers Health survive a bad year?
Health · 1 of 6 checks passed. The balance sheet carries real risk - read the checks before anything else. chapter →
What does Hims & Hers Health hand back to shareholders?
Shareholder returns · 0 of 6 checks passed. What comes back to owners is thin or stretched - read the checks before counting on it. chapter →
Which way is HIMS trending?
Trend analysis · 3 of 6 checks passed. Mixed signals from the market - some trends up, some rolling over. chapter →
Are insiders buying or selling HIMS?
Open-market buys: $0.00 · sells: $7M, across the recent Form 4 filings. detail →
Method: figures computed deterministically from SEC EDGAR XBRL (companyfacts, frames, financial-statement-and-notes datasets, Form 4); prices delayed end-of-day. Scores count transparent pass/fail checks. Missing data is shown as missing, never estimated. Last changed . © TenQ - cite with a link to this page.